好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Prognostic performance of serum neuron specific enolase (NSE) in comatose cardiac arrest survivors: a multiple thresholds meta-analysis
Neuro Trauma, Critical Care, and Sports Neurology
N6 - Neuroscience in the Clinic: Multimodal Tools for Cardiac Arrest Neuroprognostication (6:10 PM-6:20 PM)
002

Despite several systematic reviews, meta-analysis of studies on NSE after cardiac arrest has been challenging due to, a) variable cutoffs reported in each study and b) multiple cut-offs within the same study for each time point.

To determine optimal threshold of serum NSE for prediction of poor outcome after cardiac arrest using a multiple thresholds meta-analysis model

Data from a 2014 systematic review (ERC 2014) were updated with literature searches from Pubmed, Cochrane and Scopus until May 2020. Cohort studies on comatose (GCS < 8) survivors aged > 16 y, which defined poor outcome as CPC 3-5 (or equivalent) were included. After grading study quality based on the AAN guideline process manual, contingency tables were extracted and combined with the ERC 2014 data. Using the multiple thresholds meta-analysis model, summary receiver-operating curves (SROC) were generated for NSE levels at time points <24, 48 and 72 h post resuscitation. Area-under-curves (AUCs) [95% CI] were calculated as well as cut-off values [95% CI] associated with false positive rate (FPR) < 5%.

 

Evidence from a total of 52 studies was reviewed; 11 studies (n = 2153) at 24 h, 22 studies (n = 3012) at 48 h, and 13 studies (n = 2605) at 72 h. Quality of evidence was low or very low for most studies due to the risk of incorporation bias. AUCs for prediction of poor outcomes were 0.64 [0.52-0.74]; 0.82 [0.76-0.87] and 0.83 [0.77-0.88] respectively. For prediction of poor outcome with FPR < 5%, NSE cut-offs (μg/L) were 50.1 [30.5-70.4] at 48 h, and 47.1 [35.8-58.6] at 72 h.

NSE had the best prognostic performance at 48-72 h. Levels above 70.4 μg/L at 48 h and 58.6 μg/L at 72 h are highly predictive of poor outcome with FPR < 5%.

 

Authors/Disclosures
Merin John
PRESENTER
Ms. John has nothing to disclose.
No disclosure on file
Gary S. Gronseth, MD, FAAN (University of Kansas) Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN.
Kartavya Sharma, MD (University of Texas Southwestern Medical Center) Dr. Sharma has nothing to disclose.